World-Class Facilities

Where Design and Innovation Meet Purpose and Quality

Our facilities stand at the forefront of gene therapy manufacturing, fully aligning to today's US FDA and EMA industry standards and embedding a fusion of innovation, quality, and function. With three locations in Columbus, Ohio our facilities are meticulously designed to support your cell and gene therapy program journeys from concept to commercialization. Explore the unique role each of our purposefully-built centers play in supporting client programs and advancing therapies from research to GMP and commercial manufacturing.

Andelyn Corporate Center Facility

Andelyn Corporate Center

Step inside the Andelyn Corporate Center (ACC), our clinical and commercial production facility built for the rigors of cell and gene therapy manufacturing. With the latest advances in construction and clean room technologies and GMP compliance enabling design and operations, the ACC is currently producing GMP and commercial-grade, high-quality viral vectors. Discover how our facility reliably advances the path to market for life-saving therapies.

Explore the ACC
Andelyn Development Center Facility

Andelyn Development Center

Explore the Andelyn Development Center (ADC), where expert and precision-based process development, preclinical manufacturing, and analytical capabilities converge. As the cornerstone of Andelyn’s rich experience in gene therapy, the ADC is at the heart of our innovation and where we meet the evolving demands of our client programs.

Explore the ADC
Andellyn Plasmid Center

Andelyn Plasmid Center

Operating out of NCH's research institute campus, the Andelyn Plasmid Center (APC) specializes in the production of high-quality research, toxicology, and GMP-grade plasmids. Established to eliminate the bottleneck of starting-material for vector production, the APC empowers our full capabilities from vector design, process development, and assay work to clinical and commercial manufacturing.

Explore the APC

Hear from Our Partners

Success Stories
Learn More About Us
“Working with Andelyn was a great choice given their history with the product, their extensive multi-product experience with the manufacturing technology used for the product, and our desire to quickly bring UX111 to MPS IIIA patients.”
Dennis Huang
Chief Technical Operations Officer and EVP, Gene Therapy Research and Development
Ultragenyx
“Purespring is excited to build on our longstanding working relationship with Andelyn to accelerate the preclinical and clinical manufacture of our innovative AAV-based gene therapies.”
Julian Hanak
CEO
Purespring Therapeutics
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.